| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/17/2008 | WO2008006927A1 Peptide and nucleotide sequences of anisakis spp., antibodies that recognise said sequences and uses of same |
| 01/17/2008 | WO2008006850A2 Compositions and methods for inhibiting hiv infections by inhibiting lerepo4 and glipr |
| 01/17/2008 | WO2008006832A1 Protein targeting to lipid bodies |
| 01/17/2008 | WO2008006564A1 Polynucleotides encoding caryophyllene synthase and uses thereof |
| 01/17/2008 | WO2008006458A2 Epitope-tag for surface-expressed t-cell receptor proteins, uses thereof and method of selecting host cells expressing them |
| 01/17/2008 | WO2008006363A2 Treatment of t-cell carcinomas using bcl11b inhibitors |
| 01/17/2008 | WO2008006202A1 Fatty acid desaturases and uses thereof |
| 01/17/2008 | WO2008006171A1 Altering the fatty acid composition of rice |
| 01/17/2008 | WO2008006169A1 Polynucleotides and methods for enhancing salinity tolerance in plants |
| 01/17/2008 | WO2007136837A9 Prostate epithelial androgen receptor suppresses prostate growth and tumor invasion |
| 01/17/2008 | WO2007136707A3 Methods and compositions related to eosinophil regulation |
| 01/17/2008 | WO2007134122A3 Plant artificial chromosome platforms via telomere truncation |
| 01/17/2008 | WO2007133730A3 Materials and methods for control of infections |
| 01/17/2008 | WO2007125173A3 Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease |
| 01/17/2008 | WO2007121396A3 Whole genome evolution technology applied to improve protein and antibody yields by cells |
| 01/17/2008 | WO2007120192A3 Methods and compositions for labeling nucleic acids |
| 01/17/2008 | WO2007117577A3 High affinity human antibodies to human il-18 receptor |
| 01/17/2008 | WO2007113688A3 Method of in vitro polynucleotide sequences shuffling by recursive circular dna molecules fragmentation and ligation |
| 01/17/2008 | WO2007109131A9 Lentiviral vectors that provide improved expression and reduced variegation after transgenesis |
| 01/17/2008 | WO2007106882A3 Recombinant mononegaviral virus vectors |
| 01/17/2008 | WO2007106073A3 Modified pathogens for use as vaccines |
| 01/17/2008 | WO2007105350A3 Catalase gene and use thereof |
| 01/17/2008 | WO2007096192A3 Production of biologically active proteins |
| 01/17/2008 | WO2007094867A3 Cell-based p38 mapk translocation assay |
| 01/17/2008 | WO2007086093A3 Inhibitors of cell migration mediated by h-prune-gsk-3 complex and uses in antitumoral therapy |
| 01/17/2008 | WO2007084954B1 Selective inhibition of ig20 splice variants to treat cancers |
| 01/17/2008 | WO2007053802A3 Drug and gene delivery by polymer nanonozzle and nanotip cell patch |
| 01/17/2008 | WO2007050099A3 Recombinant bcg strains with attenuated immunosuppresive properties |
| 01/17/2008 | WO2007047482B1 Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics |
| 01/17/2008 | WO2007016239A3 Herpes simplex virus mutant and uses therefore |
| 01/17/2008 | WO2007009018A3 Il-6 binding proteins |
| 01/17/2008 | WO2006138689A9 Improved amino acid and metabolite biosynthesis |
| 01/17/2008 | WO2006092738A3 Micrornas and related nucleic acids |
| 01/17/2008 | WO2006031264A9 Siv and hiv vaccination using rhcmv- and hcmv-based vaccine vectors |
| 01/17/2008 | WO2005019418A8 Modulation of diacylglycerol acyltransferase 2 expression |
| 01/17/2008 | WO2004072257A3 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 01/17/2008 | WO2003100074A8 Animal genotyping method |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | WO2002066670A3 46798, a human matrix metalloproteinase and uses therefor |
| 01/17/2008 | US20080016598 Maize starch containing elevated amounts of actual amylose |
| 01/17/2008 | US20080016597 Peptide Transporting To Chromoplasts In Petals And Method Of Constructing Plant Having Yellowish Petals By Using The Same |
| 01/17/2008 | US20080016596 Bacillus thuringiensis Cry gene and protein |
| 01/17/2008 | US20080016595 Polynucleotides and methods for making plants resistant to fungal pathogens |
| 01/17/2008 | US20080016594 Vector comprising nucleotide sequences coding fungicidal agents for use in generation of disease resistant plants; biological pest control |
| 01/17/2008 | US20080016593 Engrafted Plants Resistant To Viral Diseases And Methods Of Producing Same |
| 01/17/2008 | US20080016592 transgenic plants; canola, oilseed rape, soybean; host cell; seed; tocopherol biosynthesis pathway |
| 01/17/2008 | US20080016591 transgenic plant; canola, oilseed rape, soybean; host cell; seed |
| 01/17/2008 | US20080016590 Soybean cultivar 26170838 |
| 01/17/2008 | US20080016589 Soybean cultivar 5900450 |
| 01/17/2008 | US20080016588 Soybean cultivar 306612412 |
| 01/17/2008 | US20080016587 Soybean cultivar 26660135 |
| 01/17/2008 | US20080016586 Soybean cultivar 306734323 |
| 01/17/2008 | US20080016585 Celery product |
| 01/17/2008 | US20080016584 phytases belong to the acid histidine phosphatase family, are acid-stable, and expectedly of a high specific activity; animal feed |
| 01/17/2008 | US20080015347 Kind Of Fusion Protein, Gene Encoding It, Expression Method And Use Thereof |
| 01/17/2008 | US20080015346 Expression vector comprising nucleotide sequences coding bacillus delta -endotoxin for use in transformation and generation of insect resistant corn |
| 01/17/2008 | US20080015341 New hydrophobic polymer comprising fluorine moieties |
| 01/17/2008 | US20080015340 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 01/17/2008 | US20080015339 High affinity fibronectin derivatives |
| 01/17/2008 | US20080015337 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 01/17/2008 | US20080015165 Novel polypeptide |
| 01/17/2008 | US20080015164 Methods and compositions for inactivation of dihydrofolate reductase |
| 01/17/2008 | US20080015163 Mice lacking alpha 1g showing enhanced novelty-seeking and alcohol preference and therapeutic methods for mood disorders by modulating alpha 1g t-type calcium channels |
| 01/17/2008 | US20080015162 Compounds and methods for modulating gene expression |
| 01/17/2008 | US20080015161 RNAi modulation of TGF-beta and therapeutic uses thereof |
| 01/17/2008 | US20080015159 Small Synthetic Rna, a Method of Preparing the Same and Uses Thereof |
| 01/17/2008 | US20080015158 By using a double-stranded RNA (dsRNA); neurodegenerative disorder |
| 01/17/2008 | US20080015153 Pharmaceutical compositions containing the long pentraxin PTX3 |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080015149 Galectin 11 |
| 01/17/2008 | US20080015143 In Vitro Methods for Detecting Renal Cancer |
| 01/17/2008 | US20080015137 Methods and Compositions for Targeting Macromolecules Into the Nucleus |
| 01/17/2008 | US20080015116 Integrated Systems and Methods for Diversity Generation and Screening |
| 01/17/2008 | US20080015114 siRNA targeting connective tissue growth factor (CTGF) |
| 01/17/2008 | US20080014638 Culture medium containing kinase inhibitors, and uses thereof |
| 01/17/2008 | US20080014636 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker |
| 01/17/2008 | US20080014635 Methods of increasing protein expression levels |
| 01/17/2008 | US20080014634 Selective cloning of homoduplex nucleic acids |
| 01/17/2008 | US20080014633 Manipulation of plant senescence using modified promoters |
| 01/17/2008 | US20080014620 Fermentation of pentose sugars |
| 01/17/2008 | US20080014619 Method of production of para-hydroxycinnamic acid |
| 01/17/2008 | US20080014618 polynucleotide encoding a polypeptide comprising the amino acid sequence wherein the L-aspartic acid at position 5 of the amino acid sequence is replaced by another proteinogenic amino acid (L-valine) and wherein the polypeptide possesses citrate synthase activity |
| 01/17/2008 | US20080014613 Prokaryotic collagen-like proteins and uses thereof |
| 01/17/2008 | US20080014612 Method for producing glucose dehydrogenase from aspergillus oryzae |
| 01/17/2008 | US20080014611 Method for highly expressing recombinant glucose dehydrogenase derived from filamentous bacterium |
| 01/17/2008 | US20080014610 Container for Nucleic Acid Extraction, Method of Cleaning Solid Matrix and Relevant Cleaning Mechanism, and Method of Purifying Nucleic Acid |
| 01/17/2008 | US20080014609 Methods for Obtaining Thermostable Enzymes, Dna Polymerase I Variants from Thermus Aquaticus Having New Catalytic Activities, Methods for Obtaining the Same, and Applications to the Same |
| 01/17/2008 | US20080014608 Modified Promoter |
| 01/17/2008 | US20080014605 Method and Apparatus for Selectively Targeting Specific Cells Within a cell population |
| 01/17/2008 | US20080014593 Comprises nucleotide sequences coding membrane protein for diagnosis and treatment of nervous system, cancer, kidney, reproductive, inflammatory and metabolic disorders |
| 01/17/2008 | US20080014592 Nucleic Acid Sequence Analysis |
| 01/17/2008 | US20080014585 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 01/17/2008 | US20080014578 Method of Multiplex Microorganism Detection |
| 01/17/2008 | US20080014573 Biosample Manipulation Apparatus |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014215 Animal Bioreactors |
| 01/17/2008 | US20080014212 Cloned genomes of infectious hepatitis C viruses and uses thereof |
| 01/17/2008 | US20080014210 Peptides and antibodies to muc 1 proteins |
| 01/17/2008 | US20080014208 Fusion proteins, uses thereof and processes for producing same |
| 01/17/2008 | US20080014206 drug screening for agents potentially useful in the treatment of Mycobacterium tuberculosis infection; drug resistant antibiotics |